About US
Contact us
-
AstraZeneca to cut nearly 100 jobs at U.K. site as efficiencies 'hammer' workersLess than two years after revealing a multimillion-dollar upgrade plan for its plant in Macclesfield, U.K., AstraZeneca is cutting back, slashing almost 100 jobs in what local union called a “hammer2019/3/27
-
Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unitHealth and corrections officials in Louisiana are one step closer to treating thousands of hepatitis C patients who previously haven't hadaccess to the latest drugs. The state chose Gilead Sciences’2019/3/26
-
Merck CEO Frazier has learned to 'tune out' critics, thanks to early advice from his fatherWhen Merck CEO Kenneth Frazier was a teenager growing up in inner-city Philadelphia, his father gave him the “single most important piece of advice I’ve ever been given in my entire life,” he said du2019/3/26
-
UK MHRA recalls more batches of sartan medicationThe UK Medicines and Healthcare Products Regulatory Agency (MHRA) has recalled three batches of Losartan tablets amid fears of contamination caused by N-nitroso-N-methylamino butyric acid (NMBA). The2019/3/25
-
Biogen and Eisai terminate trial of Alzheimer’s drug on efficacy groundsBiogen and Eisai have announced they are discontinuing two Phase III trials, Engage and Emerge, evaluating the safety and efficacy of aducanumab in patients with Alzheimer’s disease and mild Alzheime2019/3/25
-
Novo Nordisk, aiming for approval this fall, puts first-ever oral GLP-1 drug up for FDA reviewNovo Nordisk has big hopes for its new oral version of GLP-1 diabetes drugsemaglutide, and on Wednesday, it took onestep closer to turning those hopes into reality. Novo officiallysubmittedan applica2019/3/22
-
Puma Biotech to pay PPD founder $22M in defamation suit from proxy fightYears ago, Puma Biotechnology beat PPD founder and ex-CEO Fred Eshelman’s attempt to grab more control over its board. But thanks to a Tuesday jury verdict, the biotech now owes Eshelman $22.3 millio2019/3/22
-
C2 Pharma doubles down on supplies of digoxin APIC2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes difficult-to-get drug. The Luxembo2019/3/21
-
Merck KGaA investing €1B at headquarters site as part of 5-year work agreementMerck KGaA’s headquarters site in Darmstadt, Germany, is the pride of its international operations, and it intends to keep it that way. The German drug and materials maker says it has nailed down new2019/3/21
-
Lilly's $7M tax abatement in Indianapolis draws bipartisan pushback: reportsEli Lilly rolled out an $850 million investment plan for the U.S. two years ago, with a chunk of that earmarked for its hometown. But one of those Indianapolis building projects is getting some pushb2019/3/20